Are you Dr. Lim?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 24 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
800 Spruce St
Philadelphia, PA 19107Phone+1 215-829-3000Fax+1 215-829-7564
Summary
- Dr. Megan Lim, MD is a board certified pathologist in Philadelphia, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania, New York, and Mississippi. She is affiliated with Pennsylvania Hospital, Hospital of the University of Pennsylvania, and Penn Presbyterian Medical Center.
Education & Training
- University of Calgary Faculty of MedicineClass of 1988
- National Institutes of Health Clinical CenterFellowship, Hematopathology
Certifications & Licensure
- NY State Medical License 2022 - 2026
- NJ State Medical License 2018 - 2025
- PA State Medical License 1993 - 2024
- IL State Medical License 2020 - 2023
- KY State Medical License 2020 - 2023
- TN State Medical License 2020 - 2023
- CA State Medical License 2020 - 2022
- American Board of Pathology Anatomic Pathology
- American Board of Pathology Hematology
- American Board of Pathology Molecular Genetic Pathology
- Join now to see all
Clinical Trials
- Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma Start of enrollment: 2011 May 01
Publications & Presentations
PubMed
- 1298 citationsThe 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, Ayoma D Attygalle, Iguaracyra Barreto de Oliveira Araujo
Leukemia. 2022-07-01 - 1452 citationsThe 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.Joseph D Khoury, Eric Solary, Oussama Abla, Yassmine Akkari, Rita Alaggio
Leukemia. 2022-07-01 - 41 citationsActivating KRAS mutations are characteristic of oncocytic sinonasal papilloma and associated sinonasal squamous cell carcinoma.Aaron M. Udager, Jonathan B. McHugh, Bryan L. Betz, Kathleen T. Montone, Virginia A. LiVolsi
The Journal of Pathology. 2016-08-01
Press Mentions
- Team Establishes First Diagnostic Criteria for Idiopathic Multicentric Castleman DiseaseFebruary 16th, 2017